Toronto Dominion Bank’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
Other funds holding FENC
SCA
SGL
DCM
SCM
HFA
GJL
Toronto Dominion Bank's FENC Position: Q2 2024 in Review
Toronto Dominion Bank sold out of Fennec Pharmaceuticals (FENC) in Q2 2024, closing a stake of 25 shares — an estimated $278 sold.
Toronto Dominion Bank first reported a position in FENC in Q3 2017 and held it in 22 quarters. The position peaked at $204K in Q1 2023. 64 funds tracked by Wall St. Rank hold FENC as of Q2 2024.
- Toronto Dominion Bank reported no remaining Fennec Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Toronto Dominion Bank sold 25 Fennec Pharmaceuticals shares in Q2 2024, an estimated $278.
- Toronto Dominion Bank first reported a position in Fennec Pharmaceuticals in Q3 2017 and held it in 22 quarters.
- Toronto Dominion Bank's Fennec Pharmaceuticals position peaked at $204K in Q1 2023.
- 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2024.
Based on Toronto Dominion Bank's 13F filing for Q2 2024, filed 14 Aug 2024.